(Press-News.org) COLUMBUS, Ohio – New research shows that infectious disease-fighting drugs could be designed to block a pathogen's entry into cells rather than to kill the bug itself.
Historically, medications for infectious diseases have been designed to kill the offending pathogen. This new strategy is important, researchers say, because many parasites and bacteria can eventually mutate their way around drugs that target them, resulting in drug resistance.
In this study, scientists showed that using an experimental agent to block one type of an enzyme in cell cultures and mice prevented a specific parasite from entering white blood cells, a step required for the parasite to cause infection. This method applies to pathogens that must enter a host cell to survive and do their damage. Some bugs can thrive in a host body outside cell walls.
The researchers tested the experimental drug against Leishmania parasites, which are transmitted by the bite of infected sand flies. The pathogen causes a parasitic skin infection common in tropical and subtropical regions of the world, with an estimated 1.5 million new cases diagnosed each year worldwide.
"This represents a new way of thinking about treatment for infectious diseases. This was a proof of concept to see whether this emerging strategy is viable," said Abhay Satoskar, professor of pathology at Ohio State University and senior author of the study. "We aren't claiming we have a new drug for treatment. If we know this strategy works, then drugs can be developed that target different pathways in the host that could be important for pathogen invasion and survival."
The research appears online this week in the early edition of the Proceedings of the National Academy of Sciences.
Leishmania essentially hijacks a host's white blood cells to cause a skin infection called cutaneous leishmaniasis, characterized by sores of various sizes that may or may not be painful.
The standard compounds used to treat the skin disease must be injected and can cause damage to veins and a host of unpleasant symptoms. The side effects, combined with the need to receive daily shots for three weeks, lead to poor patient compliance – which can then allow the parasites to develop resistance to the drugs.
To work around pathogens' abilities to circumvent treatment, scientists have begun developing agents that target specific elements of the infection process inside the host body. One such experimental drug is called AS-605240, and it targets one type of an enzyme that is activated when white blood cells recognize an intruder and the host body initiates an immune response.
This enzyme, PI3K gamma, controls cell movement as well as changes to a cell membrane that enable a pathogen to penetrate the cell wall. AS-605240 blocks the activity of the gamma form of the enzyme, which in turn is expected to reduce the number of cells recruited to an infection site and allow few pathogens to enter into the cells that are recruited.
Satoskar and colleagues ran a series of experiments on animal cell cultures to demonstrate that the PI3K gamma enzyme does indeed control white blood cell activity in the immune response to Leishmania mexicana infection and that the presence of the experimental agent significantly reduced the ability of the parasites to penetrate white blood cell walls. The agent also reduced the number of phagocytes – one type of white blood cell – that were recruited to the infection site, meaning the parasites had fewer chances to find cells that could host them.
Additionally, the researchers tested these same responses in mice, with the same results. They then compared AS-605240 treatment of Leishmania infection in mice with the current standard drug treatment, sodium stibogluconate. After two weeks of treatment of lesions on the mice, the effects of both the experimental agent and the standard treatment were very similar, and both treatments reduced the number of parasites within skin lesions when compared with untreated lesions. When the treatments were combined, the healing effects were stronger than they were in mice that received just one type of treatment.
From here, Satoskar wants to fine-tune the strategy and consider other host-based pathways that could be safely manipulated to prevent pathogens from causing infection. The findings in this work suggest that such a strategy could be used not just for treatment, but for prevention as well.
"There is no prevention for these kinds of diseases," Satoskar said. "If we had a drug that would reduce the amount of phagocytes coming to the site of infection after parasites enter the skin, that would lead to a less severe infection that the body could probably control on its own."
Some people can self-heal from a Leishmania infection, but the time it takes is unpredictable so infections are typically treated, he said.
###
Satoskar's research lab is supported by funding from the National Institutes of Health.
Co-authors of this study include Hannah Cummings, Joseph Barbi, Patrick Reville, Steve Oghumu, Nicholas Zorko, Tracy Keiser, Sanjay Varikuti, Claudio Lezama-Davila and Stéphanie Seveau of the Department of Microbiology, and Anasuya Sarkar and Mark Wewers of the Davis Heart and Lung Research Institute, all at Ohio State; Bao Lu of Harvard Medical School; Thomas Rückle of Merck Serono, the manufacturer of AS-605240; Ohio State Vice President for Research Caroline Whitacre; Danuta Radzioch of McGill University; and Christian Rommel of Intellikine Inc.
Contact: Abhay Satoskar, (614) 366-1734; abhay.satoskar@osumc.edu (E-mail is the best way to initiate contact with Dr. Satoskar.)
Written by: Emily Caldwell, (614) 292-8310; caldwell.151@osu.edu
END
Wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment, according to a study published today in Neurology, the medical journal of the American Academy of Neurology.
The study looked at individuals with mild cognitive impairment (MCI), the stage between normal aging and dementia when others begin to notice that an individual is developing mild memory or thinking problems. Many older adults with MCI go on to develop Alzheimer's disease.
The study looked at 74 non-smokers with MCI and an average age of 76. Half of the patients ...
Over the past 10 years, Americans drank more sugar-sweetened beverages than ever—as much as 13 billion gallons a year—making these drinks the largest source of added sugar and excess calories in the American diet and, arguably, the single largest dietary factor in the current obesity epidemic. While many states have a sales tax on soda, experts believe they are too low to impact consumption. In a study conducted at Columbia University Medical Center and the University of California, San Francisco, researchers estimated that if a higher, penny-per-ounce tax were imposed ...
CHICAGO -- A 2010 outbreak of Legionnaires' disease in Wisconsin has been linked to a decorative fountain in a hospital lobby, according to a study published in the February issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
When the outbreak of Legionnaires' disease was detected among eight people in southeast Wisconsin, state and local public health officials worked closely with hospital staff to launch an investigation to determine the source of the outbreak. Legionnaires' disease is a severe and ...
ALBANY, Calif. -- An interactive tool developed by researchers from the USDA Forest Service's Pacific Southwest Research Station (PSW) will help wind energy facility operators make informed decisions on efficient ways to reduce impacts on migratory bats.
Fatalities of migratory bats at wind energy facilities have become a frequent occurrence. Bat migration patterns are poorly understood and the relationship between fatalities at wind energy facilities and migratory behavior are still being studied. Previous research has shown that adjusting the operations of turbines ...
Rice University researchers have figured out what gives armchair nanotubes their unique bright colors: hydrogen-like objects called excitons.
Their findings appear in the online edition of the Journal of the American Chemical Society.
Armchair carbon nanotubes – so named for the "U"-shaped configuration of the atoms at their uncapped tips – are one-dimensional metals and have no band gap. This means electrons flow from one end to the other with little resistivity, the very property that may someday make armchair quantum wires possible.
The Rice researchers show armchair ...
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer. Despite aggressive modes of treatments, myeloma ultimately remains incurable. The disease has a high incidence in the communities served by SUNY Downstate.
The findings, published in a recent issue of Journal of Oncology, are the result of a collaborative effort among researchers working in the laboratory of Olcay Batuman, MD, ...
OAK RIDGE, Tenn -- The prospect of electronics at the nanoscale may be even more promising with the first observation of metallic conductance in ferroelectric nanodomains by researchers at Oak Ridge National Laboratory.
Ferroelectric materials, which switch their polarization with the application of an electric field, have long been used in devices such as ultrasound machines and sensors. Now, discoveries about ferroelectrics' electronic properties are opening up possibilities of applications in nanoscale electronics and information storage.
In a paper published in ...
BATAVIA, Illinois, and BERKELEY, California –Two teams of physicists at the U.S. Department of Energy's Fermilab and Lawrence Berkeley National Laboratory (Berkeley Lab) have independently made the largest direct measurements of the invisible scaffolding of the universe, building maps of dark matter using new methods that, in turn, will remove key hurdles for understanding dark energy with ground-based telescopes.
The teams' measurements look for tiny distortions in the images of distant galaxies, called "cosmic shear," caused by the gravitational influence of massive, ...
BOSTON, MA -- Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
In their latest study with researchers from Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital, the BWH team created a drug delivery ...
Superior Restoration announced today it has renewed its partnership with Disaster Kleenup International (DKI), LLC, North America's largest disaster restoration contracting organization. Superior Restoration is San Diego's premier disaster cleanup and construction firm, providing 24-hour water damage restoration, fire damage repair and mold remediation services.
By renewing its DKI membership, Superior Restoration will continue to utilize DKI's 24-hour call center, its DIAMOND claims tracking technology, and other tools to enhance its ability to serve its insurance and ...
